Seattle, Wash., and Menlo Park, Calif.-based healthcare-focused investment firm Frazier Healthcare Partners announced that Bob Baltera, Howard Dittrich, M.D., and Brian Farmer have joined the Life Sciences team as Entrepreneurs-in-Residence.
The group has formed Hawkeye Therapeutics, a search company focused on in-licensing and developing high-quality assets from pharmaceutical companies headquartered in San Diego, Calif.
Mr. Baltera is a pharmaceutical executive with business and product management experience. He was formerly Chief Executive Officer of Amira Pharmaceuticals Inc., which was acquired in 2011 by Bristol-Myers Squibb. Mr. Baltera also worked at Amgen, Inc. for 17 years, and held numerous senior management positions, including Vice President of Corporate and Contract Manufacturing.
Dr. Dittrich is a cardiologist with experience in clinical research and regulatory affairs. He has co-founded several companies, including NovaCardia, which was acquired in 2007 by Merck & Co. Dr. Dittrich has served as the Chief Medical Officer for multiple companies, including NovaCardia, Sequel Pharmaceuticals, Inc., and Sorbent Therapeutics.
Mr. Farmer is a corporate development executive. He has served as Vice President of Corporate Development and Operations at Sequel Pharmaceuticals, Inc., and also led Corporate Development at NovaCardia.
Founded in 1991, Frazier Healthcare Partners is a provider of growth capital to healthcare companies across the United States, Canada and Europe. The firm has over $2.4 billion in committed capital under management and has made investments in over 170 healthcare companies, with investment types ranging from company creation and venture capital to growth buyouts and leveraged recapitalizations.